MYCRONIC AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 381.8 SEK | +2.47% |
|
+1.27% | +32.85% |
| Apr. 18 | Transcript : Mycronic AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| Apr. 18 | Mycronic AB Provides Sales Guidance for the Full Year 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 18,124 | 23,994 | 20,595 | 19,096 | 28,049 | 37,263 | - | - |
| Enterprise Value (EV) 1 | 17,787 | 22,955 | 20,155 | 18,092 | 26,137 | 34,360 | 33,432 | 37,263 |
| P/E ratio | 21.2 x | 34.6 x | 24.9 x | 25.8 x | 28.1 x | 24 x | 23.2 x | 19.3 x |
| Yield | 1.76% | 1.22% | 1.42% | 1.79% | 1.57% | 1.18% | 1.6% | 1.82% |
| Capitalization / Revenue | 4.21 x | 6.18 x | 4.44 x | 2.82 x | 4.92 x | 5.55 x | 5.21 x | 4.66 x |
| EV / Revenue | 4.13 x | 5.91 x | 4.35 x | 2.67 x | 4.58 x | 5.12 x | 4.67 x | 4.66 x |
| EV / EBITDA | 13.6 x | 20.6 x | 16.1 x | 15.8 x | 17.4 x | 15.2 x | 14.7 x | 13.8 x |
| EV / FCF | 40.8 x | 23.2 x | 22.2 x | - | - | 18.8 x | 19.3 x | 19.1 x |
| FCF Yield | 2.45% | 4.32% | 4.51% | - | - | 5.33% | 5.17% | 5.23% |
| Price to Book | 6.08 x | 7.1 x | 5.15 x | 4.06 x | 5.31 x | 5.84 x | 4.96 x | 4.14 x |
| Nbr of stocks (in thousands) | 97,917 | 97,775 | 97,608 | 97,529 | 97,597 | 97,597 | - | - |
| Reference price 2 | 185.1 | 245.4 | 211.0 | 195.8 | 287.4 | 381.8 | 381.8 | 381.8 |
| Announcement Date | 2/6/20 | 2/10/21 | 2/9/22 | 2/10/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,307 | 3,882 | 4,635 | 6,783 | 5,706 | 6,713 | 7,153 | 7,992 |
| EBITDA 1 | 1,307 | 1,112 | 1,254 | 1,147 | 1,499 | 2,266 | 2,273 | 2,702 |
| EBIT 1 | 1,124 | 898 | 1,049 | 894 | 1,235 | 1,945 | 1,993 | 2,422 |
| Operating Margin | 26.1% | 23.13% | 22.63% | 13.18% | 21.64% | 28.97% | 27.86% | 30.3% |
| Earnings before Tax (EBT) 1 | 1,122 | 890 | 1,046 | 890 | 1,262 | 2,082 | 1,878 | - |
| Net income 1 | 855 | 694 | 828 | 741 | 998 | 1,559 | 1,609 | 1,939 |
| Net margin | 19.85% | 17.88% | 17.86% | 10.92% | 17.49% | 23.22% | 22.49% | 24.27% |
| EPS 2 | 8.740 | 7.100 | 8.480 | 7.590 | 10.22 | 15.92 | 16.43 | 19.81 |
| Free Cash Flow 1 | 436 | 991 | 908 | - | - | 1,832 | 1,728 | 1,948 |
| FCF margin | 10.12% | 25.53% | 19.59% | - | - | 27.29% | 24.16% | 24.37% |
| FCF Conversion (EBITDA) | 33.36% | 89.12% | 72.41% | - | - | 80.85% | 76.02% | 72.1% |
| FCF Conversion (Net income) | 50.99% | 142.8% | 109.66% | - | - | 117.52% | 107.4% | 100.44% |
| Dividend per Share 2 | 3.250 | 3.000 | 3.000 | 3.500 | 4.500 | 4.500 | 6.103 | 6.933 |
| Announcement Date | 2/6/20 | 2/10/21 | 2/9/22 | 2/10/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|
| Net sales | 1,295 | 1,135 | 1,692 | - | - | - |
| EBITDA | 260 | 263 | 660 | - | - | - |
| EBIT 1 | 204 | 206 | 599 | 422 | 474 | 450 |
| Operating Margin | 15.75% | 18.15% | 35.4% | - | - | - |
| Earnings before Tax (EBT) | - | 204 | 616 | - | - | - |
| Net income | - | 164 | 489 | - | - | - |
| Net margin | - | 14.45% | 28.9% | - | - | - |
| EPS 2 | - | - | 5.000 | 3.410 | 3.830 | 3.730 |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/9/22 | 4/21/22 | 4/18/24 | - | - | - |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 337 | 1,039 | 440 | 1,004 | 1,912 | 2,903 | 3,831 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 436 | 991 | 908 | - | - | 1,832 | 1,728 | 1,948 |
| ROE (net income / shareholders' equity) | 32.1% | 22.1% | 22.4% | 16.9% | 20% | 26.7% | 23% | 23.2% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | 17.2% | 16.4% | 15.9% |
| Assets 1 | - | - | - | - | - | 9,083 | 9,837 | 12,174 |
| Book Value Per Share 2 | 30.50 | 34.60 | 40.90 | 48.20 | 54.10 | 65.40 | 77.00 | 92.20 |
| Cash Flow per Share | 5.570 | 11.50 | 10.20 | - | - | - | - | - |
| Capex 1 | 109 | 135 | 90 | - | 103 | 201 | 184 | 240 |
| Capex / Sales | 2.53% | 3.48% | 1.94% | - | 1.81% | 3% | 2.57% | 3% |
| Announcement Date | 2/6/20 | 2/10/21 | 2/9/22 | 2/10/23 | 2/8/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
381.8
SEK
Average target price
420
SEK
Spread / Average Target
+10.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +32.85% | 3.4B | |
| +25.98% | 360B | |
| +18.14% | 121B | |
| +10.67% | 19.99B | |
| +5.56% | 18.83B | |
| +35.96% | 9.77B | |
| +24.11% | 9.34B | |
| -7.97% | 7.54B | |
| -23.57% | 6.08B | |
| +36.78% | 5.4B |
- Stock Market
- Equities
- MYCR Stock
- Financials Mycronic AB
